Enter Note Done
Go to previous page in this tab
Session
  • Presentation | Abstracts: Systemic Sclerosis & Related Disorders - Treatment (2905-2910)
  • Abstract Session
  • Bookmark Icon
  • 2905: VERANDA™-SSc: Design of a Phase III, Double-blind, Randomized, Placebo-controlled Trial Evaluating the Safety and Efficacy of Oral Nerandomilast Treatment on Halting Disease Progression in Systemic Sclerosis
  • Schedule
    Notes
  • W304A-H
    2905
    Set Timezone

Session Type
General Topics
Format
Main Session